Literature DB >> 8541345

Ubiquitin fusion proteins are overexpressed in colon cancer but not in gastric cancer.

G F Barnard1, M Mori, R J Staniunas, N A Begum, S Bao, M Puder, J Cobb, K L Redman, G D Steele, L B Chen.   

Abstract

A cDNA clone (AF3) encoding the ubiquitin A gene 52 amino acid extension fusion protein (UbA52) was isolated from a subtracted cDNA library of human colorectal carcinoma minus adjacent normal mucosa. In Northern hybridization the mRNA signal for UbA52 was greater in surgical samples of colonic carcinoma (T) than in paired adjacent normal (N) tissues in 24 of 29 cases (T/N = 3.4 +/- 0.5, P < 0.01). An oligonucleotide probe specific for only the 52 amino acid extension confirmed the overexpression of UbA52. In contrast, there was no overexpression of UbA52 mRNA in gastric cancer samples (n = 7, T/N = 1.0 +/- 0.3). The mRNA of several ribosomal proteins, and of another ubiquitin A gene fusion protein, UbA80, with an 80 amino acid extension of ribosomal protein S27a, have been reported to be over-expressed in colon cancer, but not as yet at the protein level. Using rabbit antisera to the ribosomal protein component S27a we demonstrate over-expression of S27a at the protein level in colonic (n = 5), but not gastric (n = 6) carcinomas. Therefore it is likely that both UbA80 and UbA52 are overexpressed in colon cancer, but not in gastric cancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8541345     DOI: 10.1016/0925-4439(95)00079-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Development and validation of a novel mitophagy-related gene prognostic signature for glioblastoma multiforme.

Authors:  Jinghua Wang; Xinqi Qiu; Jiayu Huang; Zewei Zhuo; Hao Chen; Ruijie Zeng; Huihuan Wu; Kehang Guo; Qi Yang; Huiling Ye; Wei Huang; Yujun Luo
Journal:  BMC Cancer       Date:  2022-06-13       Impact factor: 4.638

2.  Determining protein biomarkers for DLBCL using FFPE tissues from HIV negative and HIV positive patients.

Authors:  Pumza Magangane; Raveendra Sookhayi; Dhirendra Govender; Richard Naidoo
Journal:  J Mol Histol       Date:  2016-10-01       Impact factor: 2.611

3.  Ultra-High Mass Resolution MALDI Imaging Mass Spectrometry of Proteins and Metabolites in a Mouse Model of Glioblastoma.

Authors:  M Dilillo; R Ait-Belkacem; C Esteve; D Pellegrini; S Nicolardi; M Costa; E Vannini; E L de Graaf; M Caleo; L A McDonnell
Journal:  Sci Rep       Date:  2017-04-04       Impact factor: 4.379

4.  LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52.

Authors:  Qianwen Zhou; Zhibo Hou; Siyu Zuo; Xin Zhou; Yadong Feng; Yong Sun; Xiaoqin Yuan
Journal:  Cancer Sci       Date:  2019-02-28       Impact factor: 6.716

5.  Differentially expressed tRFs in CD5 positive relapsed & refractory diffuse large B cell lymphoma and the bioinformatic analysis for their potential clinical use.

Authors:  Qingyuan Qu; Ying Li; Xiaosheng Fang; Lingyan Zhang; Chao Xue; Xueling Ge; Xin Wang; Yujie Jiang
Journal:  Biol Direct       Date:  2019-11-27       Impact factor: 4.540

6.  Downregulation of Methionine Cycle Genes MAT1A and GNMT Enriches Protein-Associated Translation Process and Worsens Hepatocellular Carcinoma Prognosis.

Authors:  Po-Ming Chen; Cheng-Hsueh Tsai; Chieh-Cheng Huang; Hau-Hsuan Hwang; Jian-Rong Li; Chun-Chi Liu; Hsin-An Ko; En-Pei Isabel Chiang
Journal:  Int J Mol Sci       Date:  2022-01-01       Impact factor: 5.923

7.  The ubiquitin hybrid gene UBA52 regulates ubiquitination of ribosome and sustains embryonic development.

Authors:  Masanori Kobayashi; Shigeru Oshima; Chiaki Maeyashiki; Yoichi Nibe; Kana Otsubo; Yu Matsuzawa; Yasuhiro Nemoto; Takashi Nagaishi; Ryuichi Okamoto; Kiichiro Tsuchiya; Tetsuya Nakamura; Mamoru Watanabe
Journal:  Sci Rep       Date:  2016-11-10       Impact factor: 4.379

8.  Quantitative ubiquitylomics reveals the ubiquitination regulation landscape in oral adenoid cystic carcinoma.

Authors:  Wen Li; Xiaobin Wang; Qian Zhang; Hanlin Wang; Wenxin Zuo; Hongliang Xie; Jianming Tang; Mengmeng Wang; Zhipeng Zeng; Wanxia Cai; Donge Tang; Yong Dai
Journal:  Biosci Rep       Date:  2021-08-27       Impact factor: 3.840

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.